Researchers Developed New Single-Cell RNA Sequencing Method

The newly debuted CHART-seq technology improves scalability and lowers costs for single-cell genetic analysis.

Updated on Sept. 24, 2026 in Life Sciences

A close-up of a pipette tip dispensing liquid into a laboratory tube, highlighting precision genetic research tools.
Researchers have debuted CHART-seq, a new single-cell RNA sequencing technology designed to improve scalability and reduce costs for high-resolution genetic analysis. AI Illustration. Upload story photo >

Scientists have introduced CHART-seq, a new high-resolution single-cell RNA sequencing method designed to address previous scaling challenges. This technique enables researchers to perform library preparation more efficiently than earlier plate-based full-length methods.

Why it matters

Previous plate-based full-length single-cell RNA sequencing methods were notoriously difficult to scale. CHART-seq offers a more accessible and reproducible alternative for studying cellular gene expression at a significantly lower cost.

CHART-seq allows for the processing of 96 cells per library in just 3 hours at a reagent cost of under US$1 per cell. The method supports expansion to 384-well plates and retains broad genebody coverage for reproducible expression estimates.

The details

The technology uses orthogonally indexed Tn5 complexes to tagment RNA/cDNA heteroduplexes, allowing for early sample pooling. It demonstrated superior performance in gene detection and isoform annotation compared to existing protocols such as Smart-seq2, Smart-seq3, Flash-seq, and SHERRY2.

Timeline

  1. September 24, 2026: CHART-seq development report published.

The Big Picture

This development represents a shift toward more accessible high-throughput genomics, moving away from the complex protocols required by legacy sequencing tools. By overcoming these technical hurdles, CHART-seq unlocks new possibilities for rapid, cost-effective single-cell studies.

Researchers can utilize this method to conduct more extensive studies with tighter budgets, potentially accelerating discoveries in developmental and disease-related biology. The protocol's efficiency could eventually lead to faster clinical diagnostic developments or more detailed maps of cellular inflammatory responses.

The takeaway

The development of CHART-seq demonstrates that optimizing standard laboratory workflows can significantly improve the speed and affordability of advanced genomic analysis. Scientists looking to refine their single-cell sequencing processes should evaluate how this cost-effective method compares to their current protocols.

Further reading

Learn more about the latest innovations in genetic research in the Life Sciences section.

Source note: This article includes information reported by Biorxiv.